Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Acadia Pharmaceuticals Inc

NASDAQ: ACAD · Life Sciences · 7 alerts · CIK 1070494

Share price
$18.67Close, Nov 16
Market cap
$3.23B
Shares outstanding
172.83MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Acadia Pharmaceuticals Inc filings on SEC EDGAR ↗

4:53 PM ET 8-K
Leadership Change

Acadia Pharmaceuticals Leadership Change

Elizabeth H.Z. Thompson, Ph.D., has stepped down from her role as Executive Vice President and Head of Research and Development at Acadia Pharmaceuticals effective October 23, 2026. Dr. Thompson will transition to a consulting role through December 31, 2026, while the company continues its search for a permanent replacement.

Term
through Dec 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.